Search Results 771-780 of 18218 for Lupus

  1. A Study to Investigate the Effectiveness and Safety of Pf-04965842 in Subjects Aged 12 Years and Over, With Moderate to Severe Atopic Dermatitis with the Option of Rescue Treatment in Flaring Subjects - Mayo Clinic

    Currently have active forms of other inflammatory skin diseases, ie, not AD or have evidence of skin conditions (eg, psoriasis, seborrheic dermatitis, Lupus) ...

  2. What's Marathon Medicine? (pkg) - Mayo Clinic News Network

    Number of Factors Can Contribute to Fatigue in Patients with Lupus. Related Articles. Mayo Clinic study demonstrates safety, feasibility of delivering ...

  3. Cancer pain: Relief is possible - Mayo Clinic News Network

    The medications and treatment for pain are generally covered by standard insurance. Starting from the beginning may lead to better outcomes for lupus · Mayo ...

  4. Sulindac (oral route) - Side effects & dosage - Mayo Clinic

    Systemic lupus erythematosus (SLE)—May cause side effects to become worse. Back to top. Proper Use. For safe and effective use of this medicine, do not take ...

  5. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid - Mayo Clinic

    ... lupus, inflammatory bowel disease, rheumatoid arthritis, etc.), other severe endocrinological, gastrointestinal, hepatobiliary, metabolic, pulmonary, or ...

  6. Publications - Brent P. Little, M.D. - Mayo Clinic

    CT Morphologic Characteristics and Variant Patterns of Interstitial Pulmonary Fibrosis in Systemic Lupus Erythematosus. Radiol Cardiothorac Imaging. 2021 ...

  7. A Study to Compare Three Chemotherapy Regimens for the Treatment of Patients with Newly- diagnosed Mantle Cell Lymphoma - Mayo Clinic

    Prothrombin time (PT)/international normalized ratio (INR) or partial thromboplastin time (aPTT) in the absence of lupus anticoagulant) < 2 x institutional ...

  8. Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    * Kidney biopsy findings in addition to IgAN including those of diabetic nephropathy, membranous nephropathy, or lupus nephritis. Hypertensive vascular ...

  9. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis - Mayo Clinic

    Active rheumatic autoimmune disease other than SSc requiring treatment with disease-modifying therapy, including, but not limited to, RA, systemic lupus ...

  10. Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants - Mayo Clinic

    Is taking IS therapy [eg, glucocorticoids, cyclosporine, mycophenolate, tumor necrosis factor (TNF) inhibitors] for multiple sclerosis, systemic lupus ...